Sweden vs Zambia: Access to anti-retroviral drugs, female
Sweden
96.0%
in 2022
Zambia
96.0%
in 2024
Sweden rank
14th
Zambia rank
14th
Access to anti-retroviral drugs, female over time
- Sweden
- Zambia
How they compare
Sweden currently reports 96.0% against 96.0% in Zambia, a difference of 0.0%.
Across all 23 years both countries report, Sweden has been ahead every year.
Sweden ranks 14th and Zambia ranks 14th of 141 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sweden | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.9% | 10.5% | 31.4% | Sweden |
| 2010s | 89.5% | 60.0% | 29.5% | Sweden |
| 2020s | 95.7% | 90.7% | 5.0% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Sweden or Zambia?
- Sweden, at 96.0% against 96.0% in Zambia as of 2022.
- What is the difference in access to anti-retroviral drugs, female between Sweden and Zambia?
- 0.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and Zambia?
- 23 years are reported by both, from 2000 to 2022.
- How do Sweden and Zambia rank globally for access to anti-retroviral drugs, female?
- Sweden ranks 14th and Zambia ranks 14th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.